A previously published study reported that a higher mRNA expression level of DSG2 predicted a significantly poorer prognosis in TCGA-PAAD, whereas DSG2 protein expression in PC tumor tissues detected by immunohistochemical staining in the in-house cohort showed no significant prognostic value [34]. The gene discussed is DSG2; the disease is pachyonychia congenita.